Health Clinical Challenges: FLT3 Inhibitors After Allo-Transplant in AML Eli Pacheco Jan 7, 2022 0 Relapse after allogeneic hematopoietic cell transplantation (HCT) in acute myeloid leukemia (AML) is an extremely risky clinical…
